Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Salix Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Saturday, August 11, 2012 - 12:47pm
tags:
Salix
Medicis Pharmaceutical's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Saturday, August 11, 2012 - 12:45pm
tags:
Medicis, earnings
Alexza Pharmaceuticals Reiterated With An Outperform At JMP Securities
Seeking Alpha
Saturday, August 11, 2012 - 12:44pm
tags:
Alexa
K-V Pharmaceutical Company : K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court
4-Traders
Saturday, August 11, 2012 - 12:43pm
tags:
KV Pharmaceutical
Sun Pharma to spin off local biz net up 59%
Business Standard, India
Saturday, August 11, 2012 - 12:42pm
tags:
Sun Pharma
Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
Sacramento Bee, CA
Saturday, August 11, 2012 - 12:41pm
tags:
Simcere, earnings
6 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, August 11, 2012 - 12:32pm
tags:
Eli Lilly, Elan, Merck, Pfizer, Lannett, Acura Pharmaceuticals
Durect Corporation: A Biopharma With No Debt
Seeking Alpha
Saturday, August 11, 2012 - 12:21pm
tags:
Durect Corporation
Will This Pharmaceutical Rally in 2012?
Motley Fool
Saturday, August 11, 2012 - 12:20pm
tags:
Eli Lilly
Amarin Buyout Rumors Gaining Traction?
Seeking Alpha
Saturday, August 11, 2012 - 12:19pm
tags:
Amarin, M&A, Merck, GSK
Abbott Labs Shows Slow Growth, Solid Dividends
investors.com
Saturday, August 11, 2012 - 12:17pm
tags:
Abbott Laboratories
2 Healthcare Upgrades Investors Should Consider
Seeking Alpha
Saturday, August 11, 2012 - 12:16pm
tags:
MannKind, Sanofi
Horizon Pharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Seeking Alpha
Saturday, August 11, 2012 - 12:15pm
tags:
Horizon Pharma, earnings
Pharma Giants Nervous As India Contemplates Regulating Patented Drug Prices
Seeking Alpha
Saturday, August 11, 2012 - 12:12pm
tags:
A Growth-Free Quarter -- and That's OK
Motley Fool
Saturday, August 11, 2012 - 12:11pm
tags:
Seattle Genetics
Johnson & Johnson's Deceptive Valuation
Seeking Alpha
Saturday, August 11, 2012 - 12:05pm
tags:
JNJ
Bristol-Myers Squibb: Avoid This Short-Term Laggard
Seeking Alpha
Saturday, August 11, 2012 - 12:05pm
tags:
Bristol-Myers Squibb
Eli Lilly And Stock To Go Ex-dividend Monday (LLY)
The Street
Saturday, August 11, 2012 - 12:01pm
tags:
Eli Lilly
Strong But Vulnerable
Motley Fool
Saturday, August 11, 2012 - 12:01pm
tags:
Abbott
Stem Cell Therapy Gaining Ground And Investor Attention
Seeking Alpha
Saturday, August 11, 2012 - 11:43am
tags:
stem cells, Osiris Therapeutics, Aastrom Biosciences, NeoStem, Baxter International

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.